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ABSTRACT 
The adoption of blockchain shows a variety of benefits owing to an incorruptible digital 
ledger and a decentralized database. This has eliminated the need for a gatekeeper to oversee all 
associated transactions.  Blockchain, the underlying technology behind bitcoin and other crypto-
currencies, has found use in many industries besides finance, such as healthcare, where it has 
shown promise in several use-cases. Patient data is collected using a plethora of devices, such as 
wearables or IoT-enabled home use medical devices. These types of devices are utilized in 
telehealth and provide the ability to remotely monitor the patient’s health condition.  This 
requires the patient to perform measurements themselves in their home (such as vital signs), 
which puts the burden of reliable and precised patient exam data in the hands of the patients. The 
purpose of this quantitative study is to increase the understanding of what factors affect data 
usability generated by these devices, with the findings that the surveyed medical professionals 
are concerned that patients may have issues setting up the device in the home, operating the 
device properly (including not positioning themselves or the device correctly), the provider not 
knowing where the patient resides during measurement, or the patient’s inability to determine 
when a device has malfunctioned. Upon analyzing blockchain’s capabilities, it was discovered 
that blockchain cannot fix all identified hurdles, however, it can be used (in conjunction with 
smart contracts) to limit invalid data transmission to the provider.  It was discussed that 
blockchain may also be utilized to overcome interoperability issues caused by the inability of 
most Electronic Medical Records (EMRs – sometimes also referred to as Electronic Health 
Record – EHR) to communicate and provide the patient governance of his/her own medical 
record. While there are interoperability issues amongst blockchain themselves, Estonia, for 
v 
instance, has harnessed the power of a single blockchain for digital security and has overcome 
this interoperability issue. 
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CHAPTER 1.    INTRODUCTION  
Telehealth & Remote Patient Monitoring 
At the time of the last census in 2010, around 60 million of the U.S. population (19%) 
lived in rural areas (United States Census Bureau, 2020).  Residents living in those areas are 
many times not able to travel to healthcare providers due to several circumstances, mainly based 
on economic hardships and geographical isolation. Therefore, these patients are not able to get 
routinely examined by a primary care or family physician and show higher “prevalence of 
chronic diseases such as diabetes, cancers, arthritis, and heart disease (Murray, 2006). 
Telehealth has shown promise to overcome these barriers of the geographically secluded 
patients, allowing healthcare providers and facilities to use “electronic information and 
telecommunication technologies to support long-distance clinical health care, patient and 
professional health-related education, public health, and health administration” (Health 
Resources & Service Administration (HRSA). 
Remote patient monitoring (RPM) is a category of telehealth and collects patient health 
data outside of traditional clinical settings and transmits this to the healthcare provider, enabling 
health care professionals to evaluate, diagnose and in some cases treat patients remotely.  This 
patient health data, or patient-generated data, is collect via home use medical devices or 
wearables. 
 
Wearables & Home Use Medical Devices 
Wearables are tiny, web-enabled (or IoT - Internet of Things) computers and sensors 
worn on our body. These devices capture a variety of patient-generated data, such as step count, 
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sleep quality or heart rate to provide insight of potential health conditions, such as sleep apnea or 
hypertension.  
This data is usually transmitted to an edge gateway which in many cases is a smartphone 
or tablet, and from there transferred (via different types of communication protocols, such as 
WIFI, bluetooth or cellular) to a healthcare provider’s Electronic Medical Record (EMR) or a 
data warehouse where the incoming data is organized and then transported to the provider 
(“store-and-forward”). 
 
Telehealth Opportunities in a Changing Healthcare Environment 
The vast adoption of IoT-enabled home use medical devices and wearables by patients 
and healthcare facilities has allowed health providers to navigate a changing reimbursement 
system, and at the same time shift to a value-based care system. Value-based care is a healthcare 
delivery model that focuses on the patient’s health, d healthcare providers get paid based on the 
patient’s health outcome.  This new model will impact how physicians treat patients - less tests 
will be performed in the healthcare facility (physician office and/or hospital) and telehealth/RPM 
will allow to monitor the patient’s health, and at the same time better manage patients’ chronic 
diseases, such as sleep apnea - by monitoring sleep patterns with a Continuous Positive Airway 
Pressure (CPAP) device.   
With the switch to this new model, \the CMS (Centers for Medicare & Medicaid 
Services) announced three new CPT (Current Procedure Terminology) codes for reimbursement 
of remotely monitoring patients via telehealth (Wicklung, 2018). 
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  CPT code 99453: “Remote monitoring of physiologic parameter(s) (e.g., weight, blood 
pressure, pulse oximetry, respiratory flow rate), initial; set-up and patient education on 
use of equipment.” 
 CPT code 99454: “Remote monitoring of physiologic parameter(s) (e.g., weight, blood 
pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily 
recording(s) or programmed alert(s) transmission, each 30 days.” 
 CPT code 99457: “Remote physiologic monitoring treatment management services, 20 
minutes or more of clinical staff/physician/other qualified healthcare professional time in 
a calendar month requiring interactive communication with the patient/caregiver during 
the month.” 
Home use medical devices and wearables, including health and fitness trackers, have 
become a major part of our lives.  The research firm Berg predicts that “by 2021, there will be 
50.2 million remotely monitored using connected healthcare devices, compared to 7.1 million in 
2016” (Cohen, 2017). This is a compounded annual growth rate (CAGR) of 47.9%.   
This trend shows that telehealth is here to stay, and the most-recent developments caused 
by the COVID-19 pandemic provides further opportunities for Telehealth, as many patients in 
rural areas are encouraged to not leave their homes amid the outbreak of this virus.   
 
Data Usability Generated by Wearables & Home Use Medical Devices  
There are a variety of usability challenges that appear when the patient or the patient’s 
caregiver is responsible for the device operation at his/her home.  This ranges from proper device 
operation and ensuring that the generated data has been sent properly to the healthcare provider, 
to the need to set up the device correctly (if a home use medical device was provided by the 
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healthcare provider, such as a spirometer) at the patient’s home network so the data will be 
transmitted reliably. 
There are also safety risks to the patient if the device is not used properly. The FDA has 
therefore issued Human Factors guidelines describing the need to apply “Human Factors and 
Usability Engineering to Medical Devices” (U.S. Food & Drug Administration, 2016), such as 
the recommendation to add a Human Factors Use-Related Risk Analysis (URRA) validation for 
a Graphical User Interface (GUI) present on the screen of a wearable or home use medical 
device.  These guidances have been released to ensure that the device interface operation by 
patients or their care-givers is safe for everybody involved. 
Besides safety risks, inaccurate data recording can also happen when the patient is not in 
the proper environment during data acquisition (being stressed at work vs resting at his/her 
home), or if a patient is not using the device accurately since no medical professional is 
supervising the examination. For instance, there are many steps involved to receive an accurate 
as well as precised blood pressure reading, such as to have “feet flat on floor and back 
supported” (Muntner, 2019). During the blood pressure measurement, there will not be a medical 
professional in the home to remind the patient of this guidance.   
Another usability issue that could have an impact on data quality is a device that requires 
calibration or stopped working accurately, leading to inaccurate patient data transfer, or the 
patient having to perform an exam and his/her home without a medical professional walking 
him/her through the exam.   
If the device completely stops working or the exam is not performed properly, data will 
not be transferred.  This is also true when a patient is not compliant and will not engage in the 
program as requested by the healthcare provider.  The patient may start out motivated, but 
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compliance to the examination schedule will drop.  With the shift to the discussed value-based 
care, providers need to rely on the patient’s motivation to use and wear the device regularly and 
properly, but it can be hard for the user to build a new routine. One missing data link can lead to 
a miss-interpretation of the data, which can have serious consequences, ranging from impacting 
the patient’s treatment plan to jeopardizing a patient’s health in general.  
 
Blockchain 
Blockchain is an innovative technology that promises to transform many industries, 
including healthcare, due to its incorruptible digital ledger and decentralized database.  
Blockchain is secure and is used for cryptocurrencies, such as bitcoin, to perform secure 
payments.   
In finance, each time a new transaction takes place, a new block of data is generated. 
Once the block is created, it is linked to the chain of previously created blocks, building an 
irreversible chain that becomes an immutable database. Unique to each created block is a 
fingerprint called “hash,” which also serves as the links that holds the chain together. Since these 
blocks include a specific summary of the previous block in the form of the secure hash, and are 
structured in the form of a chain, the content of transactions cannot be manipulated and makes 
this tamperproof. 
Microsoft (Azure) and Amazon (AWS – Amazon Web Services) have recently started to 
integrate blockchain infrastructure into their respective cloud platforms in order to leverage their 
service offerings (Ajoy, 2018). The growing popularity of these cloud platforms by healthcare 
and life science companies could be leveraged to store patient-generated data using blockchain 
as access control for these data repositories.  
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Do due its strong security measures and decentralized technology, Blockchain holds 
promise to be applied in healthcare to overcome the challenges of data usability, besides its 
already established benefits of keeping data secure.  
This thesis investigates if blockchain can be applied to overcome the described data 
usability challenges of home use medical devices and wearables.  This analysis will be 
performed through reviewing existing literature to further identify usability challenges of these 
devices, as well as use-cases blockchain has been used for.  Additionally, a survey was 
administered to medical professionals in order to get quantitative feedback on their experience 
regarding RMP and its challenges.   
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CHAPTER 2.    LITERATURE REVIEW 
The present topic of usability challenges of data that was generated via telehealth (remote 
patient monitoring) and its challenges include different components and has been studied only 
minimally.  Also, previous research on how blockchain can be applied to be used for wearables 
and home use medical devices is scarce. 
Therefore, the literature review has been organized in different categories, with the goal 
to apply the key concepts of each category discussed to the overall discussion and conclusion of 
this thesis.  This review focuses on  
 Wearables & Home Use Medical Devices – Technical Solutions 
 Wearables & Home Use Medical Devices - Data quality 
 Wearables & Home Use Medical Devices – Generated data sets 
 Wearables & Home Use Medical Devices - Motivation for use 
 Wearables & Home Use Medical Devices – Usability 
 Telehealth & Blockchain 
 
Wearables & Home Use Medical Devices – Technical Solutions 
 
In order to avoid the need for the patient to travel to a medical facility for a health check-
up (in particular ECG data), Ungrean (2017) proposes an IoT system that was developed for 
recording the patient’s ECG signals, recorded from his/her home, with the data transmitted to the 
medical facility. The ECG included a Bluetooth component.  This enabled sending the data to an 
internet-enabled notebook or smartphone, which allowed data transmission to the facility for data 
analysis. The author states that a limitation of these data was the accurate detection of the ECG 
signals since the system developed as cost-effective as possible. It was also stated that a Global 
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System for Mobile (GSM) mobile signal would require additional components that include 
higher computing power, therefore, increasing cost and limitations of the devices use to connect 
the device to the provider. 
A comparable approach by Archip (2016) examined how a modular monitoring system 
could be implemented to “facilitate faster and better medical interventions in emergency cases” 
for electrocardiogram (ECG or EKG) measurements, oxygen saturation (SpO2), temperature and 
movement data.  The author states that the main purpose of his study is to “fill the gap in 
monitoring a patient’s vital signs between ICU (after having undergone surgical procedures or 
other emergency treatments) and the actual hospital discharge.”  Compared to the previous study, 
the monitoring system for his study uses an edge gateway as the main component that is based 
on a Raspberry Pi B+ system.  A sensor node (mobile devices equipped with wireless IEEE 
802.15.4, as opposed to bluetooth) monitors the patient signal (such as ECG or SpO2) which the 
edge gateway collects and transmits to Android-based systems of the healthcare provider via a 
RESTful based web interface. 
While the system performed well and provided the desired data feed error-free and 
without delay, it is currently only available for Android-based devices. The article states the 
necessity of improving data security, although overall security was not discussed in detail.  Also, 
neither of these two articles discusses need for the user to properly use these devices, ensuring, 
for instance, a proper ECG signal and therefore accurate results. 
Majumder (2017) lists in the article “Wearable Sensors for Remote Health Monitoring” 
the limitations of wearables, such as its needs to manage large amount of data collected by 
sensors, battery life for long-term use, low signal-to-noise ratio (SNR), or the need for a secured 
communication channel in order to protect sensitive personal medical data when the information 
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is transmitted online.  Further challenges described are usability and ease of use, affordability of 
these devices, the need for the device to be un-obtrusive, plus the common challenge of 
interoperability amongst different sensors and applications.  It discusses home monitoring 
solutions such as camera-based systems with the limitation that these systems are pricy, complex 
and restrict the movement of the user within a specific range, and elaborates on the gained 
popularity of accelerometers, gyroscopes, and magnetometers due to their limited cost and 
versatility.   
These types of sensors may have an impact on measuring and identifying proper usability 
of wearables and home use medical devices while operating the device with limited training.  
However, small devices are low-cost devices, so many accelerometers, gyroscopes, and 
magnetometers may not be as accurate and precise as they should be and fail accurate position 
detection.   
IoT-enabled medical devices (including home use medical devices) can benefit the 
Original Equipment Manufacturer (OEM) of the device, service organizations (if different than 
the OEM) or the healthcare provider.  CFE Media (2016) describes how OEMs benefit from 
embedded device sensors once the device sold, starting with new sales activities, better targeted 
customer service and more effective new product development initiates as there is more data of 
devices in the field available. “Increase first-time fix rates and grow service margins” is one of 
those newly added capabilities that is beneficial for all stakeholders involved:  OEMs, service 
organizations and the customer/end-user as the system. Conditions can be set up that trigger an 
alert with the service team, should there be an issue.  It would practically enable the service 
person to address the issue (with the majority being done remotely) before the end-user gets 
stuck with a non-functioning device, which would be challenging given the purpose of these 
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devices in a home setting.  Another capability described is to “provide additional insight and 
advice for equipment end users” (CFE Media, 2016), which will allow the device to provide 
tailored advice to the end-user.  The article does not elaborate on the type of advice, but it seems 
possible to learn from end-user behaviors (common errors, what works and what doesn’t) based 
on the massively data sets collected. Finally, it mentions “ensure machines are used equally,” 
(CFE Media, 2016), warranting that devices are used equally and determines utilization rates for 
all systems available in a healthcare setting.  Some devices may have been “barely used while 
other devices are consistently over-used.   
 
Wearables & Home Use Medical Devices - Data Quality 
Proper device operation and the overall impact of the environment has been studied by 
Bitterman (2011).  He describes the ramification of test results due to the patient’s environment 
and the patient’s skill-set to operate a test (compared to a qualified operator).  The author also 
highlights the importance of the test location and states that hospital environments are 
“standardized, well regulated, accessible settings operating under close professional supervision 
and strict regulations” (Bitterman, 2011). Each patient’s home is unique and not a healthcare 
setting.  This uncontrolled environment may restrict appropriate testing and will possibly 
influence accuracy and precision. Therefore, Bitterman (2011) believes that the home 
environment needs to be well defined to avoid errors and achieve accurate and precise results.  
This will, in turn, motivate more users to become committed of remote services, focusing on the 
importance of patient motivation to run tests as demanded by the provider.  One aspect missing 
is the need for the medical staff to educate and train the patient in a non-intimating way and 
create a self-executing mechanism that will trigger inappropriate usage.  This could be a 
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notification when an out-of-range data set is detected, or if the device has not been used for a 
while due to lag of patient motivation. 
While wearable technology is getting increasingly popular for “monitoring training, 
recovery and health, there is not much data available regarding the validity and reliability of this 
generated data” (Düking, 2017).  Düking provides recommendations of how such evaluations 
could be established, such as including access to raw data to increase confidence in the data 
acquisition and that all sensor interoperate properly. He also stresses the need to describe the life 
of a wearable, which is dictated in large by its sensors.  These can “deteriorate or wear out” and 
are usually not routinely tested.  One important aspect to data reliability is the need to use 
wearables properly (and therefore it becomes a usability concern).  The devices are designed 
many times to be used for specific body regions, which is not always clearly indicated, or there is 
not always confidence that the device was positioned correctly.  This is especially challenging 
since these devices are used by “nonprofessionals.”  He recommends for manufacturers to clearly 
state how and where to position these devices, how to best reproduce the data and describe 
potential interference caused by other wearables in close proximity to one another. 
 
Wearables & Home Use Medical Devices – Generated Data Sets 
A big impact on data usability is the way the incoming patient-generated data is handled 
and parsed into dedicated databases, whether it is merged directly into dedicated EMR fields, a 
cloud-based solution or a proprietary database that would forward the information to an EMR 
(“store-and-forward”), or if it is stored permanently in other data repositories. 
Davidson (2013) researched clinicians’ (medical personnel) acceptability of parsing this 
incoming data directly in the EMR. For this qualitative research, the researcher interviewed 20 
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clinicians with the results that while these professionals would welcome the opportunity to 
review relevant patient data directly in the EMR, they are concerned on additional “workload” 
and “safety” (Davidson, 2013), the potential of errors being induced due to this massive amount 
of data, as well as the potential for this to disrupt the office’s workflows - should integration be 
not successful at times.  The article also states that devices allowing direct EMR data integration 
are growing in the marketplace. Additional open questions are how to “summarize the data” 
(such as by using filters so clinicians can select the displayed data) and how to ensure that data 
reliability and quality is being considered.  One respondent mentioned in the interview “all of a 
sudden you’ve got a reading which makes no clinical sense. If you could somehow remove that 
or put it there but not actually making it count with a reason for it… you can’t delete them, you 
just have to put a comment on it” (Davidson, 2016). Resolution suggestions for this topic 
included the need for good training on how to use the equipment and use proper test assessment 
techniques (which will be achieved with the newly introduced CPT codes as discussed in the 
introduction). 
Prabhu (2016) discusses the value of patient data generated at home via a telehealth 
model and claims that this “could be the source of medical breakthroughs and effective 
treatment.”  He lists telehealth advantages over conventional care, such as not being able to 
“minimize or exaggerate symptoms or constantly neglecting needed follow up visits” (Prabhu, 
2016).  He reports that a study with 24 recently discharged heart-failure patients were divided in 
2 groups where 12 patients received telehealth follow up care, and the other 12 patients received 
standard care. In the latter group, seven patients were readmitted within six months, whereas in 
the telehealth group, it was only one patient.  Prabhu then moves on to explaining that this type 
of care would be specifically beneficial for healthcare providers that are participating in pay-for-
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performance compensations as part of a value-based care system.  Engaging patients in a 
telehealth program makes monitoring the patient more efficient and will be more effective, also 
financially, than conventional standard office care.  His concerns are aligned with those studied 
in this research – data has to be usable, meaning, it needs to be interoperable and integrate into 
the physician’s workflow so the data can be accessed if needed.  This could mean EMR 
integration, or a proprietary database.  He also lists security and ongoing device maintenance 
(device calibrations) as potential problems. 
 
Wearables & Home Use Medical Devices - Motivation for Use 
Patient motivation, or patient adherence to running tests as requested and described by 
the healthcare provider is crucial to accurately monitor the patient’s health conditions.  Is there a 
method that would increase patient motivation, increase available data points and reduce the 
need to travel to a medical facility to monitor the health condition?  Sen (2014) investigates 
patient engagement among populations with high rates of non-adherence in the patient’s home 
by offering a daily financial incentive. The daily use of three home-monitoring devices during a 
three-month test period was evaluated, including a three-month follow-up period.  Devices used 
during his study were devices allowing “self-monitoring of blood glucose, blood pressure, and 
weight among patients with uncontrolled diabetes” (Sen, 2014). The device the participants 
received automatically transmitted the results to a website after each use (once daily).  Also, the 
patient was asked to confirm successful data transmission.  Upon study evaluation, the 
researchers found that the group’s participation with a financial incentive was higher than the 
control group, and after the three-month period, the group’s adherence with the incentive 
remained higher compared to the control group.  As major limitations, the research mentioned 
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that all participants came from a single primary care office, limiting this research for a certain 
geographical research only.  Also, the incentive payout was only designed for three months, and 
may have not been long enough to develop a new habit amongst the study participants.  Finally, 
one would believe that this could work in a research setting, but introducing financial incentives, 
including its payouts, is challenging in a real-life environment, where patients are needed to 
travel large distances without the ability to collect the incentives in person, or for the facility to 
mail checks to the patients on a regular basis. 
While Sen evaluated if financial incentives can increase motivation, Asimakopoulos 
(2016) evaluated the main driver of device-usage motivation. 34 global participants were asked 
to report their motivation level twice per week over a period of four weeks to determine what 
aspects drove their motivation to use these devices (in this study the participants used either a 
Fitbit or Jawbone fitness tracker).  The questions the participants had to answer where as 
follows: “reasons for wanting/using an activity tracker, reasons for choosing their specific one, 
physical activity habits and transport regime, activity tracking and barriers, motivation or 
demotivation concerning sustained use, needs and desires, impact of content that prompts 
motivational behavior, and finally support for a personalized UX” (Asimakopoulos, 2016). 
The researcher states that all users are devoted users to their device, defining this as 
“intrinsic motivation for use” (Asimakopoulos, 2016) with some participants stating they use the 
device regularly due to incentives offered by their employer.  The results reveal that UX (User 
Experience) has a direct impact on motivation, with the main drivers being data (movement, 
sleep statistics), gamification (monitoring real-time tracking) and the design of the solution. 
When tracking usage compliance or motivation over time of a new device, it is crucial to 
consider the impact of the novelty effect.  The novelty effect is defined as the “tendency for 
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performance to initially improve when new technology is instituted, not because of any actual 
improvement in learning or achievement, but in response to increased interest in the new 
technology” (Ngai, 2018).  This includes curiosity about new physical activity data, and the 
technology itself. Shin (2018) reports qualitative as well as quantitative research findings of a 
total of 23 Fitbit users who used their device between 60 and 1073 days.  The users’ log revealed 
two stages: the novelty period and the long-term use period. Based on the study results, the 
novelty period ended after approximately three months, with 14 participants continuing the 
device beyond those three months, driven by “personal motivation, social motivation, and 
gaming motivation” (Shin, 2018).  
Gouveia (2015) evaluated compliance to using a health tracker as well over a 10-month 
period with a total of 256 participants.  These participants were asked to download an application 
used for various interactions with the device, such as setting and updating personal goals.  After 
the ten-month period, the user had to delete the app. The author reports that 66% interacted with 
the app longer than two days, 38% longer than a week and only 14% longer than two weeks. As 
limitations of this study, the author points out that an app had to be used and reports that “app 
acquisition in general is highly exploratory, with only 69% of all apps being kept for longer than 
two weeks after downloading” (Gouveia, 2015), and he adds that for health-related apps it is 
even less with 1%. 
 
Wearables & Home Use Medical Devices – Usability 
To find out users’ preferences and perception on wearable usability, Jia (2018) tested 
seven fitness trackers with 388 participants for 30 days each, and surveyed the participant 
afterwards with a survey, inquiring on usability of the wearable and user preferences. For the 
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most popular preference for health management features, heart rate monitoring (4.73 highest 
number of top user selections), daily step-count (4.45), and fitness tracking (4.18) received the 
most selections, ECG monitoring (4.16) following closely. For the usability evaluation, product 
design was rated from 3.57 to 4.00 (points on Likert scale), followed by durability (3.63–4.26) 
and ease of use (3.70–3.90).  While these results do not provide more input on data usability, it 
shows that ECG monitoring is important to users, to some most important, and this is one of 
these features that requires exact instructions and proper usability to get accurate and precised 
results.  It also shows the usability preferences to be the actual looks of the device, but also 
highlights that ease-of-use is important to the participants.  
Olmos (2014) focused on remote monitoring patients that suffer under Reflex syncope, 
which is “the most common cause of syncope” (Olmos, 2014).  He discusses the challenges of 
using Holter systems for remote monitoring such health conditions or using an implantable 
monitor.  Both types, however, pose challenges regarding application duration or the need for 
invasive procedures to implant monitoring device. In his study, a wireless, non-invasive remote 
monitoring technology was tested.  The wearable was implanted in a garment, enabling 
monitoring the patient while the shirt was worn.  The mean age of the patient population was 
46 years, 31 subjects were tested.  The study compared the results of the wearable with the 
results of a conventional monitoring system. The results showed an excellent correlation of a 
Holter system with conventional ECG monitoring solutions for patients with reflex syncope. The 
study describes that this wearable includes a 3-axis accelerometer, allowing better monitoring of 
the patient’s position in real time, which will help in determining proper usability as well.  While 
the researcher doesn’t mention any limitations of this study, the author left out mentioning the 
need to build in thresholds of certain positions that would allude to improper use of the wearable 
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(wrong size, not wearing properly) and alert the physician of potentially unreliable results due to 
incorrect use of the equipment, as detected by the accelerometer.  
 
Telehealth & Blockchain 
This section will evaluate blockchain’s capabilities of providing an alternative that could 
aid in overcoming data usability challenges of wearables and home use medical devices.  The 
most viable option identified is in conjunction with blockchain-based smart contracts.  A smart 
contract is a protocol that is added to a blockchain (such as Ethereum) and executes commands 
according to the originator’s determination and a certain condition.  In a smart contract approach, 
an expected value of a patient weight, for instance, could be recorded.  Upon data receipt, the 
program validates the data value, such as weight, and automatically self-executes data 
transmission.  This technology would address some of the mentioned usability challenges and 
was investigated by Griggs (2018). 
The author created a system where sensors of a wearable (or as referred to in the 
publication as “Wireless Body Area Networks (WBANs)”) communicate via blockchain’s smart 
contracts in order to record events via a transactions log between the wearable and the healthcare 
provider, with the ability to forward the data to a designated EMR database.  This set up allows 
monitoring the patient’s device usage and enables to pre-set certain values, in the range those are 
expected. Amongst receiving out-of-range values or “unusual activity” (Griggs, 2018) the system 
would then notify the user or healthcare providers. The data coming from the wearable is sent to 
a master “smart device” (usually a smart computing device, such as phone or tablet) that serves 
as the edge gateway for collecting and formatting the raw data. Matching and formatting data 
coming from different vendors can be challenging and may require adding interfacing 
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communication protocols, which can be seen as limitation.  This, however, is not mentioned in 
the article.  As largest challenges in this setup, the authors list “maintaining security at every 
individual node” as largest challenge, especially, when data transfer is achieved via an open 
channel (such as a patient’s WIFI).  Finally, the system also lags of real-time data transfer, as it 
takes a short amount of time to verify each next block before data transfer. 
Boulos (2018) moves on to explain geospatially-enabled blockchain solutions, having the 
potential of “not just record an entry’s specific time, but also require and validate its associated 
proof of location, thus facilitating the accurate spatiotemporal mapping of physical world events” 
(Boulos, 2018).  Using geospatially-enabled blockchain opens up new opportunities for remote 
monitoring and researching the affect a certain location (such as work, location during family 
activities, doctor’s office waiting room) would have while a wearable is recording a user’s heart 
rate, for instance.  This will aid in answering the question “will utilization of a wearable or IoT-
enabled in home medical device affect the results due to not using it properly while at work, or 
skew the results since the user is sitting in a doctor’s waiting room, waiting for an upcoming 
physical?” The researcher also lists interoperability and blockchain’s security as challenge and 
questions the adoption of blockchain due to the strict privacy rules under GDPR (General Data 
Protection Regulation) within the European Union.  
Mackey (2020) evaluated if blockchain can help overcome challenges in the Japanese 
healthcare system caused by an aging population.  These challenges include “increase in national 
public health spending, higher demand for health care services, acute need for long-term care, 
shortage of health care workers, and disparities between health care access in rural versus urban 
areas” (Mackey, 2020).  The author focuses on several blockchain use-cases, such as 
“Blockchain-Based Medical Record Systems” (Mackey, 2020) and highlights the growing use 
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and demand of IoT-enabled devices in telehealth due this aging population and a shortage of 
healthcare workers.  And since “92% of adults report they own a mobile device” (Mackey, 2020) 
this could be viable solution, however, since this technology relies on the patient’s device (such 
as phone or tablet) as edge gateway to transmit the data to the healthcare provider, the risk of 
data breaches or device failure can’t be underestimated, but could, however, be alleviated with 
blockchain. This would give the patient the control over his/her data.  This added layer would 
provide additional security, would allow data integrity (a blockchain is append only, meaning, 
once a block has been added it cannot be altered - blocks can only be added) and provides 
additional benefits, such as the ability to reimburse with cryptocurrency, or create a connection 
to the EMR to monitor its transactions.  The author stated as limitations that different types of 
blockchains could limit interoperability and therefore patient data exchange. 
 “Management of consent and access to healthcare data has attracted the greatest attention 
as a potential target for blockchain-based applications” states Leeming (2019) as he analyses a 
Personalized Health Record (PHR) blockchain that aids in overcoming the current challenges of 
accessing personal health data, exchanging health data with other stakeholders as well as 
providing consent to this data.  To better understand its value, Lemming reviewed common 
features and traits of blockchain-based PHR applications, such as “health data is not stored in the 
chain” or “enabling telehealth” (Leeming, 2019).  He discusses the fact that it would not make 
sense to store a full set of health data on the blockchain due to high cost incurred by 
cryptographically encrypting the data or covering the token costs for decentralized data storage 
(deepening on the consensus algorithm used). It would rather encode the health data and points 
to the full medical record, including patient consent to access data provided by the blockchain. 
The author furthermore discusses concerns over the data quality generated by “commercial 
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fitness trackers and unvalidated health apps” as well as integration of the data and points out that 
a blockchain can interoperate more effectively with different health trackers than EMRs.  It can  
can effectively achieve this via smart contracts, connecting these data sets via their APIs to 
produce a comprehensive record. 
Shubbar (2017) focuses on remotely monitoring patients for women who undergo breast 
cancer treatment and the impact telehealth can have.  The author discusses the benefits and 
different types of telehealth and proposes a model that is used to monitor ultrasound images 
taken in remote locations and transferred to the physician using blockchain. With remote 
monitoring and blockchain integration, the author refers to “a truly accurate representation of the 
problem, by providing an integrity check on the images of the patient” (Shubbar, 2017).   He also 
discusses EMRs and the common problem for the patient’s health record, including images to be 
scattered across different health networks.  He also elaborates on the system’s ability to define 
“interoperability techniques that would coordinate data management and exchange” (Shubbar, 
2017) when the need occurs to share data and manage authentication.  Blockchain is introduced 
in order to address these interoperability challenges and integrity of the image files.  This also 
includes smart contracts that will allow a patient to have access to his or her record and enables 
communication and data sharing between the patient and the provider. 
While this seems a feasible solution, one of blockchain’s limitation is its ability to share 
large datasets, and although ultrasound generates data sets smaller compared to magnetic 
resonance imaging (MRI) or computed tomography (CT), ultrasound image files could be too 
large to be handled by a blockchain, depending on the number of images sent.  The author claims 
that the main benefit of applying the exchange of ultrasound breast imaging is “a truly accurate 
representation of the problem, by providing an integrity check on the images of the patient” 
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(Shubbar, 2017).  However, the problem is believed to be more on the image exchange itself.  
Images are usually not stored in EMRs and cannot be shared unless they are locally stored in a 
non-proprietary picture archiving communication system (PACS), which typically is only the 
case when different providers use the same PACS vendor.   
 
Literature Review Summary 
All reviewed articles reveal valuable insight with each category including a potential 
solution to overcome the challenges with the generated data of home use medical devices and 
wearables.  They also provide critical thinking considerations for implementing blockchain as 
resolution.    
Prabhu (2016) praises telehealth and claims that this “could be the source of medical 
breakthroughs and effective treatment.”  He lists advantages over conventional care, and reports 
on one study showing significantly lower re-admissions after heart-failure patients are 
discharged and then remotely monitored.  He also connects the benefits of lower cost and more 
effective patient monitoring with an overall financial benefit for the provider due to larger 
payments if enrolled in a “pay-for-performance” model as part of value-based care. 
In terms of reliability of remotely monitoring patients and comparing results of a portable 
device with a conventional ECG, Olmos (2014) reports an excellent correlation of a Holter 
system with traditional ECG monitoring solutions.  An important step and the big challenge 
compared to a conventional exam is the data transfer to the provider once the test has been 
completed. 
In order for the data to be transferred securely and completely to the healthcare facility, 
several factors have to be considered and available, with the main ones being a solid IT 
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connection in the patient’s home, an edge gateway that collects all generated data and transmits 
this information, and a reliably functioning device with enough battery life, high signal-to-noise 
ratio (SNR) with the potential impact of sensor interferences with other sensors in close 
proximity.  Ungrean (2018) suggests the use of cellular signal in a gateway.  While most of the 
time mobile phones or tablets are used as edge gateways due to its ability to store apps of the 
accompanied device and are connected (and therefore suitable to transfer the data), a potential 
solution by Archip (2016) to demand patients to stay at their home during tests is to provide a 
stationary edge gateway with the device. Bitterman (2011) proposes telehealth as risk regarding 
quality of the data, as hospitals are “standardized, well regulated, accessible settings operating 
under close professional supervision,” and the remote testing should be administered in a similar 
setting.  There are several other factors that could improve data acquisition and therefore 
usability.  Düking (2016) suggests for the vendor to provide the facility access to raw data to 
make sure there aren’t any interoperability issues with sensors in close proximity, resulting in a 
low SNR (Majumder, 2017) and to also clearly state the life and expectations of the product 
since these delicate sensors wear out easily.  Düking (2016), CFE Media (2016) and Davidson 
(2013) also stress the importance of the vendor providing sufficient training as the devices are 
designed many times to be worn on specific body regions, such as the electrodes of a Holter 
monitor.  With ECG monitoring having been identified by Jia (2018) as a top four feature set of a 
health tracker, it is crucial for the design to be fail-safe.  If the electrodes are not positioned as 
intended, results accuracy and precision will suffer. Olmost (2014) points out that a 3-axis 
accelerometer will assist the user in better positioning and better patient position monitoring in 
real time (Olmos, 2014) to overcome such positioning issue. 
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To generate accurate data, it is also important for the device to function reliably, and with 
that for the user and/or patient to identify improper functionality.  Adequate training is one 
aspect, but there were several other initiatives discussed that vendors can implement in order to 
provide peace-of-mind for the user. CFE Media (2016) suggests that devices will be able to 
predict failure due to the big data sets collected.  It will also help the facility to run utilization 
rates and don’t wear out one device while a different version of the same device is locked away 
in a drawer on a different floor.   
One of the challenges in telehealth could also be the patients’ compliance in adhering to 
the physicians’ protocols and run all tests as requested.  Both Shin (2018) and Gouveia (2015) 
report a decrease in device usage after only a short time.  While Sen (2014) reports that financial 
incentives had a positive impact on compliance, Shin (2018) explains the concept of the novelty 
effect, which will drive compliance but only lasts for about three months.  He and 
Asimakopoulos (2016) report, however, that personal motivation and gamification lead some 
participants to use the device longer.  It is crucial, however, that the devices provide a solid UX 
approach (Asimakopoulos, 2016), an intuitive user interface and an attractive design (Jia, 2018), 
without the need to log in daily to the device app to record usage.  This will detract user 
experience and decrease motivation (Gouveia, 2015).   
This summary shows that there are many solutions to identified challenges of data 
usability in telehealth, and particular in RPM.  The preferred alternative would be a solution that 
would fix all these described challenges, therefore, blockchain articles in telehealth have been 
reviewed as well to identify potential resolution opportunities.  
Griggs (2018) and Mackey (2020) both discuss very similar and viable solutions that 
could serve as the leg work to overcome potential data usability issues. In this solution, a user’s 
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wearable and/or home use medical device communicate with one another via a blockchain’s 
smart contract and the user’s phone/tablet as edge gateway, with the ability to forward the 
designated data to an EMR. Since this could be the ground-work for a valid concept, this will be 
discussed further in the Discussion section. Reported drawbacks are slow data transmission 
speeds (due to the time it takes in the chain for miners to complete the “transaction”) and 
interoperability issues.  Mackey (2020) moves on and adds that if this is to be implemented on a 
national level, it would require for each user and facility to participate in the same blockchain. 
A great add-on to overcome the issue of proper patient location during the measurement, 
Boulos (2018) proposes a geospatially-enabled blockchain solutions, with the potential to 
validate the patient’s location via smart contracts.  
A common concept for blockchain application in healthcare is its ability to provide 
consent and access rights to providers, insurers or other stakeholders by the patient, who should 
be the owner of his/her own health record.  Leeming (2019) describes efforts to utilize a 
Personalized Health Record (PHR) blockchain to manage patient consent and access to 
healthcare data, but blockchain interoperability problems and high cost to pay miners are 
identified downsides.   
Instead of using data of wearables, Shubbar (2017) describes a method to create an image 
exchange on a blockchain, with the same limitations as mentioned above, plus the fact that one 
block of a chain can only hold a limited amount of data (currently around 2MB) and image files 
may exceed this limit, depending on the imaging modality. 
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CHAPTER 3.    METHODOLOGY 
After receiving IRB approval (see Appendix C - IRB Approval Letter), quantitative 
research was performed by using a survey instrument administered via Qualtrics totaling of 17 
questions. During the Spring 2020 semester, the survey was sent to U.S. nursing managers, a 
consultant at a large U.S. health information technology solutions company as well as an online 
research community, which ensured confidentiality and the proper U.S. audience for a small fee. 
Eligibility criteria included being above 18 and being exposed to telehealth/RPM for a minimum 
of 1 year.  
Due to the outbreak of COVID-19, and the fact that most medical professionals working 
in telehealth were either taking care of patients or were involved in other essential services that 
indirectly impacted the life of many, this alternative route of utilizing an online research 
community had to be taken in order to get timely results of the necessary target audience.   
The survey included questions to gain a better understanding of RPM programs and the 
objectives of facilities engaging in RPM, such as reduced hospital stay and therefore less 
incurred cost, reduced hospital stay and therefore less potential for hospital acquired infections or 
increased patient health data (since patient is constantly monitored).  It also addressed if RPM 
could limit hypertension, diabetes, sleep apnea, chronic obstructive pulmonary disease (COPD), 
or congestive heart failure. 
An important factor that affects data usability is patient compliance to such program and 
if compliance and patient motivation can be increased by incentivizing the patient for 
participation.  The instrument contained questions regarding patient compliance as well as 
concerns the survey’s target audience had about RPM patient participation, such as patients’ data 
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privacy concerns, the patient not being able to set up device to his/her home's IT system, or 
receiving inaccurate results as the patient may not be able properly use the device consistently.  
Data accuracy could be impacted by RPM, and participants were asked to rate their 
concern for patients not being in the proper environment, and therefore the potential of the 
results not being precised (e.g., measurements intermittently taken at work or taken at home 
while resting), patients not operating equipment correctly, or the potential of a device 
malfunction while the test is performed remotely, vs at the healthcare facility. 
The participants were also surveyed how incoming data is managed (for instance, a 
data warehouse collects the data and then forwards this to an EMR) and were asked what their 
three main challenges are with an RPM model. 
Finally, the survey was set up to gauge the participants’ knowledge on blockchain.  If 
there is existing knowledge on this topic, the respondent was asked if they have seen blockchain 
applied in the healthcare environment. 
To focus on answering the research questions, specific survey items were chosen that 
directly relate to the research questions, which states as follows:  
 Does the data collected in telehealth by RPM programs pose usability challenges to 
healthcare facilities?   
 If so, what are these main challenges with RPM programs and the data collected? 
 Can blockchain be implemented to overcome these challenges? 
During the process of creating the survey instrument, the following six hypotheses were 
created to state the assumption of the research outcomes – 
 H1: The patients will not have the necessary IT knowledge to connect the home use 
medical device to his/her home network  
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 H2:  The healthcare provider’s IT uptime is spotty, which will lead data usability 
problems as not all data will be received or may be delayed 
 H3:  The patient or the patient’s caregiver was not properly trained on how to use the 
equipment.  Therefore, the device will not be operated correctly at home when there is no 
supervision by the medical professional  
 H4: Since the patient will not be at the facility’s location (either as in-patient or in 
ambulatory care), the location of the patient during a test at home is unknown, which may 
affect the precision of the results and therefore skew the data 
 H5: The device may malfunction or stop operating, which will make acquired data 
inaccurate, or perhaps there will not be any data recorded as the patient may not know 
whether the device recorded any data or not 
 H6:  The patient will be compliant to the program at first and follow the schedule 
appropriately, but the motivation will temper off and the patient’s engagement will 
decrease.  Therefore, there will not be the amount of data available that the clinician was 
hoping for in order to accurately follow the patient’s health condition. 
The below list depicts all survey items that are mostly related to the research questions 
and are used to test if the hypotheses above are supported. These core questions are listed below 
and are followed by a ranking to show how closely each item is correlated to the research 
question, with 1 being the lowest correlation and 5 the highest – 
 Patients are only motivated at the beginning of the RPM program, then device usage and 
motivation temper off slowly (4) 
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 Could you please rate each of the listed concerns below about patients participating in 
your RPM program? Patient is not able to handle device setup to his/her home's IT 
system (5) 
 Could you please rate each of the listed concerns below about patients participating in 
your RPM program? Results may be skewed results the patient won't be able to properly 
use the device consistently (4) 
 Please let us know if you agree with the following statement: The generated data of the 
equipment are NOT always transferred to us - please provide further information of an 
instance when the generated data wasn't transferred (4) 
 Could you share with us what your main concern is regarding the accuracy of the 
generated data in the patient's home? Patients aren't always in the right environment so 
test results are not precised (e.g., measurements taken at work may be different than 
measurements taken at home while resting) (5) 
 Could you share with us what your main concern is regarding the accuracy of the 
generated data in the patient's home? The device could be malfunctioning or completely 
stop working (5) 
 Please let us know briefly how the incoming data is managed (for instance, a data 
warehouse collects the data and then forwards this to the EHR (2) 
Note - Data usability challenges caused by interoperability issues among out-of-network 
EMRs and health information exchanges (HIE) have not been addressed in this thesis. These are 
challenges that healthcare vendors have been attempting to solve, including large corporations.  
Out of scope were also ergonomics referring to comfort levels when the device is worn, and 
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ethical topics regarding Health Insurance Portability and Accountability Act (HIPAA) privacy 
rights. 
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CHAPTER 4.    RESULTS 
A total of 35 participants completed or partially completed the survey. Of those 35 
participants, the responses collected of 14 participants were eliminated due to inadequate 
answers provided, showing that there was little to no background in telehealth and RPM.  
Table 1 illustrates the participants’ mean age of 41.9 years (SD = 10.4) and the mean 
experience in their current role of 9 years (SD = 4.3). 14 participants were female, 7 were male. 
Of the 21 completed surveys, the following lists the role of each participant and the sample size 
of each in parenthesis – 
 Nurse (5) 
 Nurse Practitioner (3) 
 Physician (6) 
 Physician Assistant (2) 
 Certified Nursing Assistant (1) 
 Manager (4 - Clinical team manager, Psychologist, Vice President for a Telemedicine 
Network, one manager did not mention the type of managing role) 
 
Table 1.  Research Participants and Demographics 
Role N Mean Age Age SD 
Mean Work 
Experience 
Work Experience 
SD 
Nurse  5 39.5 10 11.1 3.1 
Nurse Practitioner 3 42.8 15.3 6.4 3.8 
Physician 6 41.2 9.8 8.8 5.1 
Physician Assistant 2 34.5 7.1 5.3 4.6 
Certified Nursing 
Assistant 
1 29.5 0 8.6 0 
Manager 4 52 5 10.8 4.8 
Total 21 41.9 10.4 9 4.3 
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Managers had the highest mean age of 52 years and the second most experience of 10.8 
years, close to Nurses, who had a little more experience with 11.1 years and a mean age of 39.5 
years.  The age of all Managers was closely aligned with a SD = 5, while for the work 
experience, it was the Nurses who had a low diversity in age (SD = 3.1). The age diversity of 
Nurse Practitioner was high with a (SD = 15.3), with a low diversity in work experience (SD = 
3.1).   
Figure 1 summarizes all identified six close-ended core questions of what could be 
causing data usability challenges when patients or their caregivers independently perform 
medical tests at their homes and/or away from the healthcare facility in a remote location.  The 
questions shaded in blue are agree/disagree questions, and the questions in blue/yellow/orange 
asked the participants whether they had concerns about the given statement.   
To get a better visual whether the stated hypotheses is supported or rejected, each of the 
specified hypothesis will be listed below in bold and followed by the corresponding question 
results.  
H1: The patients will not have the necessary IT knowledge to connect the wearable 
or home use medical device to his/her home network 
Only 5% (one respondent) don’t have concerns that patients are able to set up the device 
properly in their home environment, meaning, 95% show concerns that the patient may not be 
able to manage all necessary IT steps for the device to transmit data successfully to the 
healthcare provider. Therefore, this can be considered a major challenge in an RPM program. 
H2:  The healthcare provider’s IT uptime is spotty, which will lead data usability 
problems as not all data will be received or may be delayed 
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An unreliable network at the healthcare provider facility would mean no incoming data or 
delayed incoming data.  There is a disagreement that the generated data is not always transferred 
properly to the facility due to an unreliable network.  Of 18 respondents, 12 respondents (66.7%) 
do not agree that data transfer to their facility is an issue.  Of all respondents that did agree, 
meaning, they believe that data is not always transferred correctly, the mean working experience 
in their role is 5.7 years (SD = 3.0), and 75% of those respondents are physicians (with four out 
of six physicians in total that participated in the survey).  This implies that physicians desire 
more data to aid in the patient’s treatment and may not be fully on-board with RPM being a 
viable alternative to standard visit at the physician’s office. For these six participants that agreed 
with this statement, five of those also agreed with the statement that compliance to device usage 
tempers off slowly after initiation of the program, with four being physicians, also suggesting 
that these personas desire more health data. Also, all respondents that agree with this statement 
raised concerns over the fact that patients will not be able to set up the device at his/her home IT 
network properly. 
H3:  The patient or the patient’s caregiver was not properly trained on how to use 
the equipment.  Therefore, the device will not be operated correctly at home when there’s 
no supervision by the medical professional 
When it comes to actual usability of the home use medical device or wearable during 
RPM at home, (compared to having a test performed at the healthcare facility), the majority of 
respondents (70%) had some concern about device operation without medical personnel 
supervision, while 30% (six respondents) did not see an issue with the patient running a test the 
proper way in his/her home. While in the healthcare facility, the patient may be instructed to sit 
in a chair with both arms rested on an arm rest and having both feed on the floor during a blood 
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pressure measurement, the patient may complete this measurement while driving home from 
work or while working.   
H4: Since the patient will not be at the facility’s location (either as in-patient or in 
ambulatory care), the location of the patient during a test at home is unknown, which may 
affect the precision of the results and therefore skew the data 
55.6% (ten respondents) stated that they have concerns that data may be skewed since the 
patient may not be in the proper environment during a test procedure.  An equal 22.2% (four 
respondents) mentioned that they have a big concern (four respondents) or have no concerns 
about this (four respondents).  All respondents without concerns have a mean age of 44.5 years, 
the highest of all questions.  All respondents that did not think this was a big concern (three 
respondents) are female, and also disagreed that the generated data of the equipment is not 
always transferred to the facility.  All concerned respondents (four respondents) also had 
concerns about the patient being able to properly set the device in his/her home and agreed that 
not all generated equipment data is transferred properly to the facility. This suggests either 
limited trust in the patient’s technical knowledge or speaking from experience about the patient’s 
confidence level to manage exams such as vital sings independently in a remote location.  When 
taking a closer look, it becomes apparent that these respondents are all in direct patient contact 
(two physicians, one nurse, one nurse practitioner), implying that patients may share their 
concerns about managing exams autonomously directly with them.  
H5: The device may malfunction or stops operating, which will make acquired 
inaccurate, or perhaps there will not be any data recorded as the patient may not know 
whether the device recorded any data or not 
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These results were similar to the question that attempted to identify existing concerns that 
the medical device or wearable could be malfunctioning.  While 16.7% had no concerns, a total 
of 83.3% had concerns around this statement. If a home use medical device or wearable does not 
operate the way it should, or is not calibrated correctly, incomplete data may be  transmitted, or 
the data will be inaccurate, with the medical professionals not knowing whether the patient’s 
condition changed, or the device may need to be re-calibrated or serviced.  
H6:  The patient will be compliant to the program at first and follow the schedule 
appropriately, but the motivation will temper off and the patient’s engagement will 
decrease, and therefore there will not the amount of data available that the clinician was 
hoping for in order to accurately follow the patient’s health condition 
The majority (60%, 12 respondents) of all respondents agree that device compliance to 
remote monitoring adherence will drop, but 40% (eight respondents) disagreed, highlighting that 
there still seems high device usage compliance and more patients comply to such program than 
originally thought.  The mean work experience of all the respondents that disagreed to this 
statement is with 12.4 years (SD = 5.5) the highest for all questions. This experience and patient 
knowledge strengthen this argument and underlines the fact that patients are indeed compliant, 
which could also be a strong vehicle for the earlier-discussed value-based care system. 
The CPT codes introduced with this value-based care initiative can help motivate the 
patient by the medical professional, as a more compliant patient behavior and better health 
outcome will increase the facility’s compensation within this new pay-for-performance payment 
system. And with IoT-enabled home medical devices, such as CPAP device, many insurers 
monitor device usage and limit pay if compliance drops.   
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Figure 1. Summary of Identified Six Core Questions 
 
 
Appendix B (“Summary of Core Questions Results”) summarizes all core questions that 
could cause data usability challenges.  The tables include the sample size n for each question, 
responses for each age range and range of working experience, as well as mean age, mean 
experience in current position, and SD of each question for age and experience in current 
position.  For all questions that had “Concern but nothing that can't be resolved,” “Not a big 
concern for us” or “That's a big concern for us” as an answer options, the total concern was 
calculated and included in these tables (“That's a big concern for us” + “Concern but nothing that 
can't be resolved”).  
The seventh and final identified core question was an open-ended question that inquired 
about how the incoming data is managed.  This question is not matched with a hypothesis.  It 
was, however, identified as a core question to identify if there is a usability issue caused by 
massive data and therefore data fatigue by the medical professional.   A total of 18 participant 
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responded. 1 participant responded as N/A, and 3 responses were eliminated as the responses 
were unclear or participants just stated "use secure process" or "data is confidential.”  This leaves 
a total of 14 valid responses. The responses were categorized and evaluated, as shown below in 
Table 2.   
 
Table 2. Categorized Responses for Seventh Core Survey Question  
Directly to Cloud 21.4% 
Local Database 57.1% 
Used for Research & Managed 
Locally 
7.1% 
EMR Directly 14.3% 
 
Of all respondents that indicated that the incoming data is going through a cloud service 
or a local database first (“store-and-forward”), it is unclear whether the data stays in this 
proprietary and therefore siloed database, or if the data is forwarded to an EMR application 
afterwards. Of the three respondents (21.4%) whose answer matched the “Directly to Cloud” 
category, two indicated that the data is forwarded to the EMR afterwards. For the local database 
category (57.1%), one respondent stated that this is forwarded to the EMR. This shows that most 
facilities collect the incoming patient-generated data by a local database or cloud service first, 
with most cloud services being able to directly forward the data to the most common EMR 
system without further software tools or additional necessary hardware.  Amazon, for instance, 
advertises “AWS Healthcare Competency Partners” on their website that are able to build 
“solutions for healthcare payers and providers that securely store, process, transmit, and analyze 
clinical information” (Amazon Web Services, 2020).   
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Table 2 also shows that only 7.1% of all incoming data is not parsed into an EMR system 
and will stay in a proprietary repository for further research, with all other data eventually being 
parsed into an EMR application.   
After reviewing the seven identified core questions, it becomes evident that the strongest 
agreement occurs for patients having a difficult time setting up the patient-data-generated device 
at their home. This is followed by the fact that the device could be malfunctioning, and the 
patient may not be in the right environment during the test to ensure precise results.  Table 3 
takes a closer look at all previously listed hypotheses and whether these are supported or 
rejected.  Each hypothesis is paired with the applicable question(s).   
 
Table 3.  All Hypotheses Indicating Support or Rejection, Paired with Applicable Question(s) 
 
Hypothesis 
# 
Hypothesis 
Applicable 
Statement 
Supported Rejected Reasoning 
1 
The patient’s will not have 
the necessary IT knowledge 
to connect the home use 
medical device to his/her 
home network  
Patient is not able to 
handle device setup 
to his/her home's IT 
system 
X  
95% 
Concerned 
2 
The healthcare provider’s IT 
uptime is spotty, which will 
lead data usability problems 
as not all data will be 
received or may be delayed 
The generated data 
of the equipment are 
NOT always 
transferred to us 
 X 
66.7% 
Disagree 
3  
The patient or the patient’s 
caregiver was not properly 
trained on how to use the 
equipment. Therefore, the 
device will not be operated 
correctly at home when 
there’s no supervision by the 
medical professional 
The results may be 
not be accurate as 
the patient or 
caregiver won't be 
able properly use the 
device consistently 
X  
70% 
Concerned 
 
38 
 
 
 
Table 3 Continued 
 
Hypothesis 
# 
Hypothesis 
Applicable 
Statement 
Supported Rejected Reasoning 
4 
Since the patient will not be 
at the facility’s location 
(either as in-patient or in 
ambulatory care), the 
location of the patient during 
a medical exam at home is 
unknown, which will affect 
the precision of the results 
and therefore skew the data 
Patient isn't always 
in the right 
environment, so test 
results are not 
precised 
X  
77.8% 
Concerned 
5 
The device may malfunction 
or stops operating, which will 
make acquired data 
inaccurate, or perhaps there 
will not be any data recorded 
as the patient may not know 
whether the device recorded 
any data or not 
The device could be 
malfunctioning or 
completely stop 
working 
X  
83.3% 
Concerned 
6 
The patient will be compliant 
to the program at first and 
follow the schedule 
appropriately, but the 
motivation will temper off 
and the patient’s engagement 
will decrease, and therefore 
there will not the amount of 
data available that the 
clinician was hoping for in 
order to accurately follow the 
patient’s health condition 
Patient is only 
motivated at the 
beginning, then 
motivation & device 
usage drops 
 X 
40% 
Disagree 
 
The driver of data usability and data accuracy is clearly the incoming data, and inaccurate 
data transmitted is caused by the aforementioned factors that support the hypothesis. 
Table 4 below illustrates the driver that causes the inaccurate/limited data (all supported 
hypotheses), categorized by source, as well as a resolution suggestion (first without blockchain 
implementation) on how these challenges can be overcome. 
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Table 4.  Driver Causing Inaccurate/Limited Data of all Supported Hypothesis, Categorized by 
Source and Resolution Suggestion 
 
 
Source 
Driver Causing 
Inaccurate/Limited Data 
Resolution Suggestion 
Patient 
Patient isn't always in the 
same environment, so test 
results are not precised 
 
 
Adding a GPS sensor to a device would enable 
location tracking and therefore ensure the 
patient is in the proper environment during the 
test. While many wearables have this included, 
this is not standard for home use medical 
devices 
 
- Instead of using a phone/tablet as edge gateway, 
the device could come with its own gateway 
that requires to be set up in the patient’s home.  
This would ensure data transmission only when 
the patient is performing a test in her/her home 
 
Results may be skewed as 
patient or caregiver won't 
be able to properly use the 
device consistently 
 
 
- User errors are addressed by new FDA 
guidelines and the need to submit a usability 
validation study to get the device registered, 
including a URRA for the user interface, if 
applicable.  These only address home use 
medical devices as not all patient-generated data 
devices require FDA approval 
 
- Newly established CPT codes 99453, 99454 & 
99457 will provide payment for providers to 
work with patients on setting up device, provide 
patient education on use of equipment, and 
allow a 20-min check in time of the clinicians 
with the patient and/or caregiver 
 
- Many devices have integrated sensors (such as 
an accelerometer or gyroscope) that senses the 
proper position of the device or the body part 
attached to the device during the test.  The 
device will alert the user if the device is not 
properly positioned (such as wrist blood 
pressure monitor and its sensing of correct arm 
position while the cuff inflates) 
 
Patient is not able to 
handle device setup to 
his/her home's IT system 
 
The majority of wearables and home use 
medical devices, especially the ones 
communicating with a phone/tablet as edge 
gateway, are very user-friendly to set up and 
many times provide a setup via the phone/tablet 
app with very simple and few steps involved 
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Table 4 Continued 
 
 
 
 
After reviewing the above table, it becomes evident that a large majority of the identified 
factors that cause data usably issues (and with that inaccurate data) are caused the patient, and 
that stakeholders in this field are confident and comfortable with their IT infrastructure as well as 
other factors that are not influenced by a human.  Therefore, there is a strong likelihood for an 
increase in RPM data quality in the future once patients and their caregivers accept this shift to 
the value-based care system and this telehealth model. 
 
 
 
 
 
 
 
 
 
 
 
 
Source 
Driver Causing 
Inaccurate/Limited Data 
Resolution Suggestion 
Device Device malfunction 
 
- Machine Learning (ML) paired with AI 
(Artificial Intelligence) will make devices more 
reliable, will predict failure and notify user of 
potential issues in advance 
 
- There is a fine line between device malfunction 
and user errors. Therefore, device 
manufacturers attempt to correct this with IoT-
enabled devices that are connected to the 
manufacturer, which allows them to verify 
proper usage and functionality, and attempts to 
provide distinction between device malfunction 
or device is not properly used (such as an X-ray 
image that looks grainy – this could be a device 
malfunction, or bad patient positioning by the 
X-ray Technologist) 
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CHAPTER 5.    DISCUSSION 
 
Blockchain Application to Resole Usability Challenges 
As the results section and the literature review suggest, there are many solutions 
identified to resolve challenges of data usability in telehealth.  Many of those suggested 
technologies (such as ML, location sensing or predictive maintenance), however, are still in its 
infancy. 
The preferred alternative would be “a one solution fits all” approach.  One single solution 
that could be implemented to fix these described challenges.  One technology that could show 
potential in alleviating these depicted challenges is blockchain, in particular blockchain in 
conjunction with smart contracts.  While not a solution to solve all problems, it has potential to 
make the data exchange not only more secure, but also improve data quality. 
The below flow-charts (Figures 2 – 5) illustrate the driver causing inaccurate/limited data 
(grey hexagon shape), the identified (“conventional”) resolution solutions, as well as the benefit 
a blockchain would have on the identified driver that cases inaccurate data   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2. Resolution Solutions for “Patients aren't Always in the right Environment so 
Test Results are not precised” 
 Adding a GPS sensor to a device would enable location tracking and therefore ensure 
the patient is in the proper environment during the test. While many wearables have 
this included, this is not standard for home use medical devices 
 
 Also, instead of using a phone/tablet as edge gateway, the device could come with its 
own gateway that requires to be set up in the patient’s home.  This would ensure data 
transmission only when the patient is performing a test in her/her home 
 
Patient is not 
always in same 
environment, so 
test results are not 
precised 
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Figure 2 Continued 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  Resolution Solutions for “The results may be not be accurate as the patient or 
caregiver won't be able properly use the device consistently” 
 
Blockchain 
Alternative 
 
 User errors are addressed by new FDA guidances and the need to submit a usability 
validation study to get the device registered, including a URRA for the user interface, if 
applicable.  These only address home use medical devices as not all patient-generated data 
devices require FDA approval 
 
 Newly established CPT codes 99453, 99454 & 99457 will provide payment for providers 
to work with patients on setting up device as well as provide patient education on use of 
equipment and a 20-min check in time of the clinicians with the patient and/or caregiver 
 
 Many devices have integrated sensors (such as an accelerometer or gyroscope) that senses 
the proper position of the device or the body part attached to the device during the test.  
The device will alert the user if the device is not properly positioned (such as wrist blood 
pressure monitor and its sensing of correct arm position of the patient while the cuff 
inflates) 
A geospatially-enabled blockchain creates a time stamp and requires its 
associated proof of location as well (via smart contract), providing an immutable 
spatial context (geographic setting), allowing accurate mapping of events  
 
Patient/caregiver 
is not using device 
correctly 
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Figure 3 Continued 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.  Resolution Suggestions for “Patient or Caregiver’s Inability to set up Device in his/her 
Home's IT Network will cause transmission issues” 
 
 
 
 
The majority of wearables and home use medical devices, especially the ones communicating 
with a phone/tablet as edge gateway, are very user-friendly to set up and many times provide 
a setup via the phone/tablet app with very simple and few steps involved 
 
Patient’s inability 
to set up device in 
home's IT network 
will cause 
transmission issues 
 
N/A 
Blockchain 
Alternative 
 
This can be managed with applying smart contracts as well.  For instance, if the provider 
expects a certain blood pressure range, say between 100 – 150 mmHg / 80 – 100 mmHg, 
and the reading comes back as 160/105 mmHg due to wrong position of the patient’s arm, 
the value would not be submitted to the healthcare provider.  
 Blockchain 
Alternative 
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Figure 5.  Resolution Suggestions for “Device Malfunction so Source of Inaccurate Data 
Unclear” 
 
This analysis confirms that while blockchain will not be the cure for all, there are 
opportunities for this technology to solve some of the identified usability issues and prevent data 
to be used if invalid.   
 Machine Learning (ML) paired with AI (Artificial Intelligence) will make devices more 
reliable, will predict failure and notify user of potential issues in advance 
 
 There’s a fine line between device malfunction and user errors. Therefore, device 
manufacturers attempt to correct this with IoT-enabled devices that are connected to the 
manufacturer, which allows them to verify proper usage and functionality, and attempts to 
provide distinction between device malfunction or device is not properly used (such as an 
X-ray image that looks grainy – this could be a device malfunction, or bad patient 
positioning by the X-ray Technologist) 
 
 
Device malfunction 
so source of 
inaccurate data 
unclear 
 
Smart contracts would apply here also as they only execute and 
transmit the data when the predefined conditions are met.  If the 
data is out-of-range due to device failure, data transmission will 
not be executed 
 
Blockchain 
Alternative 
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While it is crucial for innovative technology to be employed inside a wearable or home 
use medical device (such as the proposal for vendors to monitor image quality, for instance, in 
X-ray imaging and alert the facility if there is an issue with patient positioning vs instead the 
detector may go out) or predicting failure, blockchain can assist with resolving the identified 
issues once the patient has completed his/her exam and verify the data.  Smart contracts could be 
deployed by the healthcare provider in advance to filter out-of-range test results and demand the 
patient to run these tests in their homes with a geospatial blockchain.  Similar results achieved by 
smart contracts can be accomplished with logic gates that execute (and transmit data), for 
instance, when value A or B are met, or only A or B are true.  However, using a smart contract as 
gate-keeper could automatically communicate out-of-range results or off-location data to 
everybody participating in the same blockchain. 
While not in scope and not directly related to data quality that is generated by a wearable 
or home use medical device, another promising prospect to blockchain is the potential to 
overcome the issue of interoperability, a common problem in healthcare today, in which EMRs 
cannot communicate with other out-of-network EMRs (as mentioned for instance by Shubbar 
(2017), see literature review). Today it is nearly impossible for a patient to have a full medical 
record of all physician visits in one repository, with the patient having little to no access to their 
own medical records, as those are spread across different healthcare systems and providers (such 
as cardiologist, orthopedists, primary care physician, or even dentist or ophthalmologist).  This 
creates data silos which can’t be accessed by neither the healthcare provider nor the patient 
himself with the consequence that physicians won’t always get a full picture of the patient’s 
health when needed.  This in turn could impact diagnosis and increase costs as tests may have to 
be repeated.   
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How can blockchain be plugged in to resolve this?  Due to the fact that blockchain 
eliminates the central owner of a database and every node (computer in a blockchain network) 
has access to the full ledger, the patient could control their own data and provide consent to the 
healthcare providers of the patient’s choice including physicians, pharmacy or insurance.   
One of the limitations of blockchains, however, are limited data storage per block 
(around 2 MB, depending on the type of blockchain) and its slow transaction speeds due to the 
need to solve the consensus algorithm that is executed with every transaction.  Due to this 
limitation, blockchain is not ideal to store a full medical record, but does lend itself to act as an 
access control of the actual data and points to the repository the data is stored in.  There would be 
essentially no change to the full medical record and where it resides.  But a block could be 
created which includes the node’s encrypted information and a signed permission (consent) with 
the link where it is pointing to. 
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CHAPTER 6.    CONCLUSION, LIMITATIONS, RECOMMENDATIONS 
Conclusion 
 
Blockchain technology is very promising to be applied in the healthcare field, with many 
identified use-cases, and with many more being investigated and developed. However, those are 
tested in silos by single companies and healthcare consortia, and there are currently no standards, 
which causes interoperability of blockchains itself with different healthcare providers running 
different type of blockchains by different vendors. The wide adoption of bitcoin and its 
blockchain, however, shows potential for a standard healthcare blockchain to be deployed.   
Estonia, the “The World’s Most Digital Country” (Greenwald, 2018) shows that a 
blockchain can be deployed successfully, as it became a digital society and utilizes blockchain to 
serve their state government. The country introduced a “once only” policy, which dictates that 
“no single piece of information should be entered twice (Heller, 2017) including eliminating the 
need to fill out documentation at the healthcare provider’s waiting room since “physicians can 
access their patients’ medical histories” (Heller, 2017). 
Telehealth is on a similar strong growth trajectory, but compared to blockchain, it is no 
longer in its infancy.  It is teaching patients new ways of communication with healthcare 
providers, and it is “no longer just a nice-to-have, but instead a must-have for patients and 
healthcare professionals alike’ (Harpaz, 2020).   
According to Harpaz (2020), “25% of respondents had used telehealth prior to COVID-
19. 59% reported they are more likely to use telehealth services now than previously, and 33% 
would even leave their current physician for a provider who offered telehealth access.” 
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While telehealth is growing in patient acceptance amidst the COVID-19 pandemic with 
the ability for more effective health monitoring, it is essential to the healthcare facility as well as 
better patient outcome secures higher compensation within the new pay-for-performance model.  
 
Limitations 
The following limitations were identified during analysis of the data received: 
 Limited sample size 
 Questionnaire did not ask respondents in which type of healthcare facility/area they work 
and what size it is (there is a difference of how incoming data is handled between 
research labs, small offices, large healthcare networks, or other facilities, such as mental 
health clinics) 
 Questionnaire needs to ask more around the way incoming data is handled and its impact 
(for instance, does it contribute to dissatisfaction amongst medical professionals) 
 
Recommendation for Future Work 
Focusing on Human Computer Interaction and Human Factors, it is logical to continue to 
connect telehealth and blockchain research with the human. Future research could investigate 
how the human can interact and takes full advantage of a blockchain. Having discovered with 
this work that most of the data usability challenges are caused by the patient, future research 
should include the interaction of the user with blockchain in providing consent and assigning 
access rights of patient data to healthcare providers. 
Also, a blockchain interface should be identified that depicts the workflow of a provider 
setting up smart contracts via an intuitive UI/UX that will eliminate the guess-work of the user.  
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This will be a natural next step in reviewing how blockchain can be plugged in to overcome 
usability challenges of data generated by wearables and home use medical devices in the field of 
Human Computer Interaction and Human Factors.    
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APPENDIX A.    SURVEY INSTRUMENT 
 
 
Start of Block: Introductions 
 
Thanks for participating in our survey, your feedback is highly appreciated. It should not take 
longer than 20 min to complete. We are a research team at Iowa State University, trying to 
identify the challenges of managing data that is generated by wearables, in home use medical 
devices or other health trackers via Remote Patient Monitoring (RPM) programs. The survey 
results will be used to identify if adding Blockchain technology could eliminate some of these 
challenges. Please click the blue arrow below to get started. 
 
End of Block: Introductions 
 
Start of Block: Demographics 
 
Q1 Which of the following best describes you? 
o I am a physician   
o I am a physician assistant   
o I am a nurse practitioner   
o I am a nurse   
o I am a manager (please specify below) 
________________________________________________ 
o Other (please specify below)  
________________________________________________ 
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Q2 How long have you worked in this position? 
o Less than 1 year   
o 1 - 3 years   
o 3.1 - 6 years   
o 6.1 - 11 years   
o 11.1 - 18 years   
o 18+ years   
 
 
 
Q3 Please indicate your gender 
o Male   
o Female   
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Q4 What is your age range? 
o Under 18   
o 18 - 24   
o 25 - 34   
o 35 - 44   
o 45 - 54   
o 55 - 64   
o 65 - 74   
o 75 - 84   
o 85 or older   
 
End of Block: Demographics 
 
Start of Block: Remote Patient Monitoring (RPM) Objective 
 
Q5 To start, we'd like to find out the main objective why facilities engage in an RPM (remote 
patient monitoring) program. Please indicate your response for each of the statements below.  If 
there's an important objective for an RPM program missing, please let us know under "Others 
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not listed." 
 
VERY important 
Objective  
Important Objective  Not that important  
Reduced hospital stay 
and therefore less 
incurred cost  o  o  o  
Reduced hospital stay 
and therefore less 
potential for hospital 
acquired infections  
o  o  o  
Acquire more patient 
health data (since 
patient is constantly 
monitored)  
o  o  o  
Receive more 
accurate patient 
health data since 
patient will not 
develop anxiety when 
seeing a doctor in a 
health facility  
o  o  o  
To be recognized as 
"innovative" and start 
of the art healthcare 
facility  
o  o  o  
Others not listed 
(please specify below 
and select one of the 
options provided   
o  o  o  
 
 
 
 
Q6 How do the below patient types benefit from RPM? Please indicate your response for each of 
the statements below. If there's an important patient type missing, please let us know under 
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"Others not listed." 
 Very important  Possibly  Not relevant  
Postpartum patients  o  o  o  
Diabetes patients   o  o  o  
Patients with sleep 
disorders  o  o  o  
COPD patients  o  o  o  
Patients with 
congestive heart 
failure  o  o  o  
Any patient that 
wants to participate  o  o  o  
Others not listed 
(please specify below 
and select one of the 
options provided  
o  o  o  
 
 
End of Block: Remote Patient Monitoring (RPM) Objective 
 
Start of Block: Patient Motivation 
 
Q7 Please let us know if you agree with the following statement: Patients are only motivated at 
the beginning of the RPM program, then device usage and motivation temper off slowly. 
o Agree   
o Disagree   
 
 
 
Q8 Please let us know if you agree with the following statement: In order to increase patient 
motivation, we have considered offering an incentive for the patient to stay motivated with using 
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the device and sending the generated data while home. 
o No, we haven't considered this   
o Yes, we have considered it   
o Yes, we have implemented incentive of some type   
o We had this implemented but stopped providing incentives   
 
 
 
Q9 Could you please rate each of the listed concerns below about patients participating in your 
RPM program? If we missed an important concern, please let us know under "Others not listed." 
 
That's a big Concern 
for us  
Concern but nothing 
that can't be resolved  
Not a big Concern 
for us  
Patient's concern of 
data privacy and 
security  o  o  o  
Patient is not able to 
handle device setup 
to his/her home's IT 
system  
o  o  o  
Skewed results as the 
patient won't be able 
properly use the 
device consistently   
o  o  o  
Others not listed 
(please specify below 
and select one of the 
options provided)  
o  o  o  
 
 
End of Block: Patient Motivation 
 
Start of Block: Data usability, interoperability, and security 
 
Q10 Please let us know if you agree with the following statement: The generated data of the 
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equipment are NOT always transferred to us. 
o Disagree   
o Agree (please provide further information of an instance when the generated data wasn't 
transferred ______________________________________________ 
 
 
 
Q11 Could you share with us what your main concern is regarding the accuracy of the generated 
data in the patient's home? If we missed an important concern about generated data accuracy, 
please let us know by providing details under "Others not listed." 
 
That's a big Concern 
for us  
Concern but nothing 
that can't be resolved  
Not a big concern for 
us  
Patients aren't always 
in the right 
environment so test 
results are not 
precised (e.g., 
measurements taken 
at work may be 
different than 
measurements taken 
at home while 
resting)   
o  o  o  
Patients don’t operate 
equipment correctly  o  o  o  
The device could be 
malfunctioning or 
completely stop 
working  
o  o  o  
Others not listed 
(please specify below 
and select one of the 
options provided)  
o  o  o  
 
 
 
 
Q12 Do you allow patients to use their own equipment and transfer the data that has been 
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generated by this device (such as an Apple Watch)? 
o Yes   
o No   
o We considered it but haven't done so   
o We have in the past but there have been too many issues (please provide short 
explanation below)  _______________________________________________ 
 
 
 
Q13 Please let us know briefly how the incoming data is managed (for instance, a data 
warehouse collects the data and then forwards this to the EHR) 
________________________________________________________________ 
 
 
 
Q14 In your opinion, what percentage of patients do you believe have concerns about the data 
privacy?  
o less than 5%   
o 6 - 20%   
o 21 - 25%    
o 26 - 50%   
o 51 - 75%   
o 75% +   
 
End of Block: Data usability, interoperability, and security 
 
Start of Block: Blockchain 
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Q15 Have you heard of a technology called Blockchain? If so, please let us know your 
knowledge level by selecting one of the provided options below. 
o Never heard of Blockchain    
o Heard of Blockchain, but that's it   
o Little knowledge of Blockchain   
o Advanced knowledge of Blockchain   
 
 
 
Q16 Have you seen Blockchain applied in the Healthcare field? 
o No   
o Yes (please provide short explanation below) 
________________________________________________ 
 
End of Block: Blockchain 
 
Start of Block: Summary of Main Challenges 
 
Q17 Please list the 3 main challenges you have experienced with an RPM model. 
o Challenge 1   ________________________________________________ 
o Challenge 2   ________________________________________________ 
o Challenge 3  ________________________________________________ 
o Not Applicable/we've never used RPM   
________________________________________________ 
 
End of Block: Summary of Main Challenges 
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APPENDIX B.    SUMMARY OF CORE QUESTIONS RESULTS 
 
 
 
 Range Count  Mean SD   Range Count Mean SD
Q8 - Agree 1-3' 3 25 - 34' 6
6.1 - 11' 7 35 - 44' 3
11.1  - 18' 2 45 - 54' 2
Sub-Total 60% 12 7.9 4.0 11 35.9 7.7
25 - 34' 1
Q8 - Disagree 3.1 - 6' 2 35 - 44' 3
6.1 - 11' 1 45 - 54' 3
11.1 - 18' 3 55 - 64 2
18+ 2
Sub-Total 40% 8 12.4 5.5 9 46.0 9.4
Total 20 20
Q10B - Concern but nothing 
that can't be resolved
50% 1 - 3' 2 25 - 34' 6
6.1 - 11' 4 45 - 54' 2
11.1 - 18' 3 55 - 64' 2
18+ 1
Sub-Total 10 10.1 5.3 10 39.5 12.7
Q10B - Not a big concern for 
us
5% 3.1 - 6' 1 45 - 54' 1
Sub-Total 1 5.0 0.0 1 49.5 0.0
Q10B - That's a big concern 
for us
1 - 3' 1 35 - 44' 6
3.1 - 6' 1 45 - 54' 2
6.1 - 11' 4 55 - 64' 1
11.1 - 18' 2
18+ 1
Sub-Total 45% 9 9.9 5.0 9 43.9 6.9
Total 95% 20 20
Q10C - Concern but nothing 
that can't be resolved
3.1 - 6' 1 25 - 34' 3
6.1 - 11' 5 35 - 44' 3
11.1 - 18' 1 45 - 54' 1
18+ 1 55 - 64' 1
Sub-Total 40% 8 10.1 4.2 8 39.5 10.0
Q10C - Not a big concern for 
us
30% 1 - 3' 1 25 - 34' 2
3.1 - 6' 1
6.1 - 11' 2 35 - 44' 1
11.1 - 18' 2 45 - 54' 2
6 8.8 4.7 55 - 64 1
Sub-Total 6 42.8 11.1
Q10C - That's a big cconern 
for us
1 - 3' 2 25 - 34' 1
6.1 - 11' 1 35 - 44' 2
11.1 - 18' 2 45 - 54' 2
18+ 1 55 - 64' 1
Sub-Total 30% 6 10.1 6.5 6 44.5 9.6
Total 70% 20 20
Experience in Current Position Age
%
% - Concern 
Combined 
Question
Q8 (n = 20)     Patients are only 
motivated at the beginning of 
the RPM program, then device 
usage and motivation temper off 
slowly  
Q10B (n = 20)     Could you 
please rate each of the listed 
concerns below about patients 
participating in your RPM 
program? Patient is not able to 
handle device setup to his/her 
home's IT system
Q10C (n = 20)     Could you 
please rate each of the listed 
concerns below about patients 
participating in your RPM 
program? Skewed results as the 
patient won't be able to 
properly use the device 
consistently
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Appendix B Continued 
 
 
 
 
 
 
 
 
 Range Count  Mean SD   Range Count Mean SD
Q11A - Agree 1 - 3' 2 25 - 34 2
3.1 - 6' 1 35 - 44 3
6.1 - 11' 3 55 - 64 1
Sub-Total 33.3% 6 5.7 3.0 6 39.5 10.0
Q11A - Disagree 1 - 3' 1
3.1 - 6' 1 25 - 34 4
6.1 - 11' 5 35 - 44' 3
11.1 - 18' 3 45 - 54' 5
18+ 2
Sub-Total 66.7% 12 10.9 5.2 12 40.3 8.6
Total 18 18
Q12A - Concern but nothing 
that can't be resolved
55.6% 1 - 3' 1 25 - 34' 3
6.1 - 11' 6 35 - 44 5
11.1 - 18' 2 45 - 54' 2
18+ 1
Sub-Total 10 10.0 4.46 10 38.5 7.0
Q12A - Not a big concern for 
us
3.1 - 6' 1 25 - 34' 1
6.1 - 11' 1 45 - 54' 3
11.1 - 18' 1
18+ 1
Sub-Total 22.2% 4 12.0 5.53 4 44.5 8.7
Q12A - That's a big concern 
for us
1 - 3' 2 25 - 34' 2
3.1 - 6' 1 35 - 44 1
6.1 - 11' 1 55 - 64' 1
Sub-Total 22.2% 4 4.3 2.68 4 39.5 12.3
Total 77.8% 18 18
Q12C - Concern but nothing 
that can't be resolved
44.4% 6.1 - 11' 5 25 - 34 2
11.1 - 18' 2 35 - 44' 4
18+ 1 45 - 54' 2
Sub-Total 8 11.2 3.84 8 39.5 7.1
Q12C - Not a big concern for 
us
16.7% 3.1 - 6' 1 25 - 34 1
6.1 - 11' 1 45 - 54' 2
11.1 - 18' 1
Sub-Total 3 9.2 4.11 3 42.8 9.4
Q12C - That's a big concern 
for us
1 - 3' 3 25 - 34 3
3.1 - 6' 1 35 - 44' 2
6.1 - 11' 2 45 - 54' 1
18+ 1 55 - 64' 1
Sub-Total 38.9% 7 6.5 5.72 7 39.5 10.7
Total 83.3% 18 18
Q12A (n = 18)     Could you share 
with us what your main concern 
is regarding the accuracy of the 
generated data in the patient's 
home? Patients aren't always in 
the right environment so test 
results are not precised (e.g., 
measurements taken at work 
may be different than 
measurements taken at home 
while resting)
Q12C (n = 18)     Could you share 
with us what your main concern 
is regarding the accuracy of the 
generated data in the patient's 
home? The device could be 
malfunctioning or completely 
stop working
Experience in Current Position Age
%
% - Concern 
Combined 
Question
Q11A (n = 18)     Please let us 
know if you agree with the 
following statement: The 
generated data of the 
equipment are NOT always 
transferred to us
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APPENDIX C.    IRB APPROVAL LETTER  
                        
 
 
 
 
Date:  12/11/2019 
 
To:  Steffen Baumann Richard T Stone 
 
From:  Office for Responsible Research 
 
Title:  Design characteristics of blockchain integration to enhance usability of patient-generated 
data devices. 
 
IRB ID:  19-421      
 
Submission Type:  Initial Submission    Exemption Date:   12/11/2019 
 
 
The project referenced above has been declared exempt from most  requirements of the human subject 
protections regulations as described in 45 CFR 46.104 or 21 CFR 56.104 because it meets the following 
federal requirements for exemption: 
 
2018 - 2 (iii): Research that only includes interactions involving educational tests (cognitive, diagnostic, 
aptitude, achievement), survey procedures, interview procedures, or observation of public behavior 
(including visual or auditory recording) when the information obtained is recorded by the investigator in such 
a manner that the identity of the human subjects can readily be ascertained, directly or through identifiers 
linked to the subjects, and an IRB conducts a LIMITED IRB REVIEW to [determine there are adequate 
provisions to protect the privacy of subjects and to maintain confidentiality of the data]. 
 
The determination of exemption means that: 
 
 You do not need to submit an application for continuing review.  Instead, you will receive a request 
for a brief status update every three years.  The status update is intended to verify that the study is 
still ongoing. 
 
 You must carry out the research as described in the IRB application.  Review by IRB staff is required 
prior to implementing modifications that may change the exempt status of the research.  In general, 
review is required for any modifications to the research procedures (e.g., method of data collection, 
nature or scope of information to be collected, nature or duration of behavioral interventions,  use of 
deception, etc.), any change in privacy or confidentiality protections, modifications that result in the 
inclusion of participants from vulnerable populations, removing plans for informing participants about 
the study, any change that may increase the risk or discomfort to participants, and/or any change such 
Institutional Review Board 
Office for Responsible Research 
Vice President for Research  
2420 Lincoln Way, Suite 202 
Ames, Iowa 50014 
515 294-4566 
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that the revised procedures do not fall into one or more of the regulatory exemption categories. The 
purpose of review is to determine if the project still meets the federal criteria for exemption.   
 
 All changes to key personnel must receive prior approval.    
 
 Promptly inform the IRB of any addition of or change in federal funding for this study.  Approval of 
the protocol referenced above applies only to funding sources that are specifically identified in the 
corresponding IRB application.  
 
Detailed information about requirements for submitting modifications for exempt research can be 
found on our website.  For modifications that require prior approval, an amendment to the most 
recent IRB application must be submitted in IRBManager.  A determination of exemption or approval 
from the IRB must be granted before implementing the proposed changes. 
 
Non-exempt research is subject to many regulatory requirements that must be addressed prior to 
implementation of the study.   Conducting non-exempt research without IRB review and approval may 
constitute non-compliance with federal regulations and/or academic misconduct according to ISU 
policy. 
 
Additionally: 
 
 All research involving human participants must be submitted for IRB review. Only the IRB or its 
designees may make the determination of exemption, even if you conduct a study in the future that is 
exactly like this study. 
 
 Please inform the IRB if the Principal Investigator and/or Supervising Investigator end their role or 
involvement with the project with sufficient time to allow an alternate PI/Supervising Investigator to 
assume oversight responsibility.  Projects must have an eligible PI to remain open. 
 
 Immediately inform the IRB of (1) all serious and/or unexpected adverse experiences involving risks 
to subjects or others; and (2) any other unanticipated problems involving risks to subjects or others. 
 
  Approval from other entities may also be needed.  For example, access to data from private records 
(e.g., student, medical, or employment records, etc.) that are protected by FERPA, HIPAA or other 
confidentiality policies requires permission from the holders of those records.  Similarly, for research 
conducted in institutions other than ISU (e.g., schools, other colleges or universities, medical facilities, 
companies, etc.), investigators must obtain permission from the institution(s) as required by their 
policies.  An IRB determination of exemption in no way implies or guarantees that permission from 
these other entities will be granted. 
 
 Your research study may be subject to post-approval monitoring by Iowa State University’s Office for 
Responsible Research.  In some cases, it may also be subject to formal audit or inspection by federal 
agencies and study sponsors. 
 
 Upon completion of the project, transfer of IRB oversight to another IRB, or departure of the PI and/or 
Supervising Investigator, please initiate a Project Closure in IRBManager to officially close the project.  
For information on instances when a study may be closed, please refer to the IRB Study Closure Policy.     
 
Please don’t hesitate to contact us if you have questions or concerns at 515-294-4566 or IRB@iastate.edu.  
 
 
